Perrigo (PRGO) Research & Development (2012 - 2026)
Perrigo (PRGO) reported Research & Development of $24.6 million for Q1 2026, down 7.87% year-over-year from $26.7 million in Q1 2025, and up 12.84% quarter-over-quarter from $21.8 million in Q4 2025.
Perrigo (PRGO) Research & Development (2012 - 2026) Analysis & Trends
Perrigo (PRGO) has 15 years of Research & Development data on file, last reported at $24.6 million in Q1 2026.
- Research & Development for Q1 2026 came in at $24.6 million, down 7.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $93.3 million (down 15.1% YoY), and the FY2025 annual result was $95.4 million, down 14.97% from the prior year.
- Research & Development grew to $24.6 million in Q1 2026 per PRGO's latest filing, from $21.8 million in the prior quarter.
- Over five years, Research & Development peaked at $32.6 million in Q4 2022 and troughed at $21.8 million in Q4 2025.
- A 5-year average of $28.1 million and a median of $29.3 million in 2022 frame the typical range for Research & Development.
- The sharpest annual moves came in 2022 and 2025: Research & Development climbed 7.97% in 2022, then retreated 25.17% in 2025.
- A 5-year view of Research & Development shows it stood at $32.6 million in 2022, then declined by 9.2% to $29.6 million in 2023, then declined by 6.08% to $27.8 million in 2024, then retreated by 21.58% to $21.8 million in 2025, then increased by 12.84% to $24.6 million in 2026.
- Business Quant data shows PRGO's Research & Development at $24.6 million in Q1 2026, $21.8 million in Q4 2025, and $24.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 222.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 180.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 138.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 934,363.43 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 296.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 97.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 103.35 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 39.38 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 46.94 Mn |
| 10 | Perrigo | 1.61 Bn | 1.25 Bn | 325.50 Mn | 24.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 24.60 Mn |
| Dec 31, 2025 | 21.80 Mn |
| Sep 27, 2025 | 24.90 Mn |
| Jun 28, 2025 | 22.00 Mn |
| Mar 29, 2025 | 26.70 Mn |
| Dec 31, 2024 | 27.80 Mn |
| Sep 28, 2024 | 26.00 Mn |
| Jun 29, 2024 | 29.40 Mn |
| Mar 30, 2024 | 29.00 Mn |
| Dec 31, 2023 | 29.60 Mn |
| Sep 30, 2023 | 29.60 Mn |
| Jul 1, 2023 | 32.20 Mn |
| Apr 1, 2023 | 31.10 Mn |
| Dec 31, 2022 | 32.60 Mn |
| Oct 1, 2022 | 29.80 Mn |
| Jul 2, 2022 | 31.50 Mn |
| Apr 2, 2022 | 29.30 Mn |
| Dec 31, 2021 | 30.30 Mn |
| Oct 2, 2021 | 27.60 Mn |
| Jul 3, 2021 | 33.00 Mn |